Revecard
verified Antithrombotic agents
info General information
Name Revecard, 50 mg, lyophilized powder for solution for intravenous infusion, supplied with solvent – water for injections
INN Alteplase
Active substance Alteplase
Pharmacotherapeutic group Antithrombotic agents. Enzymes. Alteplase.
Dosage form Lyophilized powder for solution for intravenous infusion, supplied with solvent – water for injections.
Packaging
50 mg of the product in glass vials. 50 mL of solvent (water for injections) in glass vials.
1 vial with the product and 1 vial with the solvent are placed in a cardboard box.
Manufacturer Karaganda Pharmaceutical Complex LLP
EU GMP
assignment_turned_in Indications
Revecard is used to treat conditions caused by the formation of blood clots in blood vessels:
- heart attack (acute myocardial infarction);
- blockage of the blood vessels of the lungs by blood clots (acute massive pulmonary embolism);
- stroke caused by a blood clot in a blood vessel of the brain (acute ischemic stroke).
